Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Forte Biosciences, Inc.

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Mr. David Gryska Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. to Review the Second Quarter 2021 Results and Expects to Announce Topline Data From Phase 2 Clinical Trial of FB-401 for the Treatment of Atopic Dermatitis on Sept. 7
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. Announces First Quarter 2021 Results and Provides a General Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Forte Biosciences, Inc. to Announce First Quarter 2021 Results and Provide a General Business Update
From Forte Biosciences, Inc.
Via Business Wire
Tickers FBRX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.